London: EU antitrust regulators are set to fine world No. 1 generic drugmaker Teva in the coming weeks for disparaging a rival product to its blockbuster multiple sclerosis medicine Copaxone ...

The announcement came a day after the city reached an $80 million settlement over opioids with drugmaker Teva Pharmaceutical. Baltimore did not disclose the terms of its settlement with Walgreens ...

Teva is poised to benefit from rising demand for generic drugs due to a favorable macro and political environment. The company's valuation is attractive despite its high debt load, which it is ...

The settlement with Teva Pharmaceuticals comes one week before the city's opioid lawsuit is set to go to trial. Ravens OLB Odafe Oweh’s $20,500 fine for unnecessary roughness in Chiefs game ...